Heart podcast
Summary: From June 2023, all our podcasts will move to https://heartbmj.podbean.com. You can continue with your subscription on your favourite podcast App. Heart is an international, peer-reviewed journal that keeps cardiologists up to date with advances in the diagnosis and treatment of cardiovascular disease. Each issue contains original research, accompanying editorials and reviews. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.
- Visit Website
- RSS
- Artist: BMJ Group
- Copyright: 643134
Podcasts:
In this podcast, Alistair Lindsay talks to Jennifer Logue about the link between obesity and heart disease.Increasing weight is associated with a higher prevalence of known risk factors for coronary artery disease, such as diabetes, high blood pressure and cholesterol. And it has been assumed that these have been responsible for the increased risk of heart disease seen in obesity, say the authors. But now research published in Heart suggests that obesity is a killer in its own right, irrespective of other biological or social risk factors traditionally associated with coronary heart disease.Read the article online: http://heart.bmj.com/content/early/2011/01/24/hrt.2010.211201
In this podcast, Alistair Lindsay talks to Jennifer Logue about the link between obesity and heart disease.Increasing weight is associated with a higher prevalence of known risk factors for coronary artery disease, such as diabetes, high blood pressure and cholesterol. And it has been assumed that these have been responsible for the increased risk of heart disease seen in obesity, say the authors. But now research published in Heart suggests that obesity is a killer in its own right, irrespective of other biological or social risk factors traditionally associated with coronary heart disease.Read the article online: http://heart.bmj.com/content/early/2011/01/24/hrt.2010.211201
Alistair Lindsay talks to Maarten Leening (Erasmus MC, The Netherlands) about his research into the risk of heart failure following undiagnosed myocardial infarctions in elderly people.See also;Unrecognised myocardial infarction and long-term risk of heart failure in the elderly: the Rotterdam Study http://bit.ly/11z3tGg
Alistair Lindsay talks to Maarten Leening (Erasmus MC, The Netherlands) about his research into the risk of heart failure following undiagnosed myocardial infarctions in elderly people.See also;Unrecognised myocardial infarction and long-term risk of heart failure in the elderly: the Rotterdam Study http://bit.ly/11z3tGg
Alistair Lindsay talks to Declan O’Regan about assessing reperfusion injury using cardiac MRI in patients with acute MI.See also;Assessment of severe reperfusion injury with T2* cardiac MRI in patients with acute myocardial infarction http://bit.ly/14MsaUf
Alistair Lindsay talks to Declan O’Regan about assessing reperfusion injury using cardiac MRI in patients with acute MI.See also;Assessment of severe reperfusion injury with T2* cardiac MRI in patients with acute myocardial infarction http://bit.ly/14MsaUf
Alistair Lindsay talks to Leong Ng about his work into using biomarkers to identify which groups of patients will benefit from ACE inhibition after acute coronary syndrome.See also:Identification of potential outcome benefit from ACE inhibition after acute coronary syndrome: a biomarker approach using N-terminal proBNP http://bit.ly/11hAfKc
Alistair Lindsay talks to Leong Ng about his work into using biomarkers to identify which groups of patients will benefit from ACE inhibition after acute coronary syndrome.See also:Identification of potential outcome benefit from ACE inhibition after acute coronary syndrome: a biomarker approach using N-terminal proBNP http://bit.ly/11hAfKc
In this first edition of the BMJ Heart podcast, Alistair Lindsay talks to Peter Bramlage about his paper on how and when patients are treated after acute myocardial infarction, and the effect optical medical therapy can have on one year mortality.See also:The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction http://bit.ly/Y1KOoj
In this first edition of the BMJ Heart podcast, Alistair Lindsay talks to Peter Bramlage about his paper on how and when patients are treated after acute myocardial infarction, and the effect optical medical therapy can have on one year mortality.See also:The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction http://bit.ly/Y1KOoj
